Boston Scientific rose over 4.4%, Q3 performance exceeded expectations + raised full-year adjusted earnings guidance

智通财经
2025.10.22 14:50
医疗器械公司波士顿科学涨超 4.4%，报 104.36 美元。消息面上，波士顿科学第三季度销售额同比增长 20% 至 50.7 亿美元，超出华尔街分析师预期的 49.7 亿美元。其中，心血管部门的销售额同比增长 22% 至 33.4 亿美元，高于预期的 32.7 亿美元。期内调整后每股收益为 75 美分，高于预期的 71 美分。公司上调全年调整后每股收益指引至 3.02 至 3.04 美元，超过分析师预期的 2.98 美元。
Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.